The 13^th International Conference on Typhoid and Other Invasive Salmonelloses will be held December 5-7 in Kigali, Rwanda. Researchers and experts from across the globe will gather to exchange the latest findings and research on typhoid, paratyphoid, and invasive non-typhoidal Salmonella disease.

UMSOM’s Center for Vaccine Development & Global Health (CVD) will be there in force, presenting research on typhoid and Salmonella vaccines. Presentations include Dr. Scott Baliban, who will share his work on the potential of a maternal vaccination strategy against nontyphoidal Salmonella (NTS) using a vaccine developed at CVD. Post-doc fellow Garima Bansal will discuss work developing two live attenuated non-transmissible invasive non-typhoidal Salmonella (iNTS) vaccine candidates that may be used in future clinical trials as potential live oral vaccines to prevent iNTS. Other CVD speakers will present on methods to assess TCV effectiveness, antibody responses to trivalent Salmonella conjugate vaccine (TSCV), and clinical development of TSCV. The Typhoid Vaccine Acceleration Consortium (TyVAC) team led by CVD will also host a symposium focusing on the full public health value of typhoid conjugate vaccines 

This conference serves as a key opportunity to advocate and coordinate a global response to typhoid and other invasive Salmonellosis through partnership, knowledge sharing, and collaboration. CVD is proud to have so many young investigators sharing their work.